Gender-dependent metabolic remodeling during heart preservation in cardioplegic celsior and histidine buffer solution

Journal of Cardiovascular Pharmacology

Volumn 59, Issue 2, 2012, Pages 151-157

  Alves, Marco G ^a,b   Oliveira, Pedro F ^c   Martins, Fátima O ^a   Oliveira, Paulo J ^a   Carvalho, Rui A ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF BEIRA INTERIOR   (Portugal)

Author keywords

cardioplegic solutions; gender; glycolysis; ischemia; metabolism

Indexed keywords

BUFFER; CELSIOR; GLUCOSE; HISTIDINE; LACTIC ACID;

ACIDIFICATION; ANIMAL EXPERIMENT; ARTICLE; CARDIOPLEGIA; COLD ISCHEMIA; ENERGY METABOLISM; FEMALE; GLUCOSE INTAKE; GLYCOLYSIS; HEART MUSCLE METABOLISM; HEART PRESERVATION; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION REDUCTION STATE; PH; PRIORITY JOURNAL; RAT; SEX DIFFERENCE;

ANIMALS; BUFFERS; CARDIOPLEGIC SOLUTIONS; COLD ISCHEMIA; DISACCHARIDES; ELECTROLYTES; ENERGY METABOLISM; FEMALE; GLUCOSE; GLUTAMATES; GLUTATHIONE; HEART; HISTIDINE; HYDROGEN-ION CONCENTRATION; LACTIC ACID; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MANNITOL; OXIDATION-REDUCTION; RATS; RATS, WISTAR; SEX FACTORS; TIME FACTORS;

EID: 84857063384     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3182391d17     Document Type: Article

References (33)

1. Muhlbacher F, Langer F, Mittermayer C. Preservation solutions for transplantation. Transplant Proc. 1999;31:2069-2070.
2. Berkich DA, Salama G, LaNoue KF. Mitochondrial membrane potentials in ischemic hearts. Arch Biochem Biophys. 2003;420:279-286. (Pubitemid 37491112)
3. Nils AT, Henri GDL, Rutger JP. New solutions in organ preservation. Transplant Rev. 2002;16:131-141.
4. Stoica SC, Satchithananda DK, Dunning J, et al. Two-decade analysis of cardiac storage for transplantation. Eur J Cardiothorac Surg. 2001;20: 792-798. (Pubitemid 33713628)
5. Biberthaler P, Luchting B, Massberg S, et al. The influence of organ temperature on hepatic ischemia-reperfusion injury: a systematic analysis. Transplantation. 2001;72:1486-1490. (Pubitemid 33095505)
6. Jahania MS, Sanchez JA, Narayan P, et al. Heart preservation for transplantation: principles and strategies. Ann Thorac Surg. 1999;68: 1983-1987.
7. Solaini G, Harris DA. Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion. Biochem J. 2005;390:377-394. (Pubitemid 41337100)
8. Morin D, Hauet T, Spedding M, et al. Mitochondria as target for antiischemic drugs. Adv Drug Deliv Rev. 2001;49:151-174. (Pubitemid 32493806)
9. Borutaite V, Brown GC. Mitochondria in apoptosis of ischemic heart. FEBS Lett. 2003;541:1-5. (Pubitemid 36428907)
10. Logue SE, Gustafsson AB, Samali A, et al. Ischemia/reperfusion injury at the intersection with cell death. J Mol Cell Cardiol. 2005;38:21-33. (Pubitemid 40044759)
11. Depre C, Vanoverschelde JL, Melin JA, et al. Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans. Am J Physiol. 1995;268:H1265-H1275.
12. Arnall DA, Palmer WK, Miller WC, et al. Effect of fasting on myocardial substrates in male and female rats. Am J Physiol. 1988;254:C560-C563.
13. Colom B, Oliver J, Roca P, et al. Caloric restriction and gender modulate cardiac muscle mitochondrial H2O2 production and oxidative damage. Cardiovasc Res. 2007;74:456-465. (Pubitemid 46693701)
14. Alves M, Oliveira P, Carvalho R. Mitochondrial preservation in Celsior versus histidine buffer solution during cardiac ischemia and reperfusion. Cardiovasc Toxicol. 2009;9:185-193.
15. Alves MG, Oliveira PJ, Carvalho RA. Substrate selection in hearts subjected to ischemia/reperfusion: role of cardioplegic solutions and gender. NMR Biomed. 2011;24:1029-1037.
16. Takeuchi K, Cao-Danh H, Kawai A, et al. Prolonged preservation of the blood-perfused canine heart with glycolysis-promoting solution. Ann Thorac Surg. 1999;68:903-907. (Pubitemid 29526858)
17. Takeuchi K, Maida K, Tanaka S, et al. Superior myocardial protection with a new histidine-buffered crystalloid cardioplegic solution in clinical trial. Thorac Cardiovasc Surg. 1999;47:148-152. (Pubitemid 29325694)
18. Rato L, Alves M, Socorro S, et al. Metabolic modulation induced by estradiol and DHT in immature rat sertoli cells cultured in vitro. Biosci Rep. 2012;32:61-69.
19. Bing RJ. The metabolism of the heart. Trans Am Coll Cardiol. 1955;5:8-14.
20. King LM, Boucher F, Opie LH. Coronary flow and glucose delivery as determinants of contracture in the ischemic myocardium. J Mol Cell Cardiol. 1995;27:701-720.
21. Di Lisa F, Menabo R, Canton M, et al. Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J Biol Chem. 2001;276:2571-2575.
22. Justo R, Boada J, Frontera M, et al. Gender dimorphism in rat liver mitochondrial oxidative metabolism and biogenesis. Am J Physiol Cell Physiol. 2005;289:C372-C378. (Pubitemid 41008883)
23. Steenbergen C, Murphy E, Watts JA, et al. Correlation between cytosolic free calcium, contracture, ATP, and irreversible ischemic injury in perfused rat heart. Circ Res. 1990;66:135-146. (Pubitemid 20033934)
24. Jousilahti P, Vartiainen E, Tuomilehto J, et al. Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation. 1999;99: 1165-1172. (Pubitemid 29120088)
25. Strehlow K, Rotter S, Wassmann S, et al. Modulation of antioxidant enzyme expression and function by estrogen. Circ Res. 2003;93: 170-177. (Pubitemid 36919705)
26. Duckles SP, Krause DN, Stirone C, et al. Estrogen and mitochondria: a new paradigm for vascular protection? Mol Interv. 2006;6:26-35. (Pubitemid 43327520)
27. Olson AK, Hyyti OM, Cohen GA, et al. Superior cardiac function via anaplerotic pyruvate in the immature swine heart after cardiopulmonary bypass and reperfusion. Am J Physiol Heart Circ Physiol. 2008;295: H2315-H2320.
28. Yu QJ, Si R, Zhou N, et al. Insulin inhibits beta-adrenergic action in ischemic/reperfused heart: a novel mechanism of insulin in cardioprotection. Apoptosis. 2008;13:305-317.
29. Xing W, Yan W, Fu F, et al. Insulin inhibits myocardial ischemiainduced apoptosis and alleviates chronic adverse changes in postischemic cardiac structure and function. Apoptosis. 2009;14: 1050-1060.
30. Doenst T, Richwine RT, Bray MS, et al. Insulin improves functional and metabolic recovery of reperfused working rat heart. Ann Thorac Surg. 1999;67:1682-1688. (Pubitemid 29301311)
31. Si R, Tao L, Zhang HF, et al. Survivin: a novel player in insulin cardioprotection against myocardial ischemia/reperfusion injury. J Mol Cell Cardiol. 2011;50:16-24.
32. Alves MG, Machado NG, Sardão VA, et al. Anti-apoptotic protection afforded by cardioplegic Celsior and histidine buffer solutions to hearts subjected to ischemia and ischemia/reperfusion. J Cell Biochem. 2011. doi: 10.1002/jcb.23320.
33. Alves MG, Soares AF, Carvalho RA, et al. Sodium hydrosulfide improves the protective potential of the cardioplegic histidine buffer solution. Eur J Pharmacol. 2011;654:60-67.